 SARS-CoV-2 variants of concern have been associated with reduced vaccine effectiveness, even after a booster dose. In this study, authors aim to estimate vaccine effectiveness against hospitalization with the Armacran and Delta variants, using different definitions of hospitalization in secondary care data. This article was authored by Julia Stowe, Nick Andrews, Frigia Kerspam and others.